Skip to main content
Top

19-07-2018 | Back pain | Article

Knowledge of features of inflammatory back pain in primary care in the West Midlands: a cross-sectional survey in the United Kingdom

Journal: Rheumatology International

Authors: T. Adizie, S. Elamanchi, A. Prabu, A. V. Pace, R. Laxminarayan, N. Barkham

Publisher: Springer Berlin Heidelberg

Abstract

Key messages

There is a relative lack of confidence among GPs in the assessment and management of IBP vs. mechanical back pain. A simple screening tool for SpA, applicable in primary care urgently needs to be developed. It is reasonable for patients with symptoms suggestive of inflammatory back pain to be referred to secondary care without further investigations.

Abstract

The objective of this study was to assess current practice of our local general practitioners (GPs) in using clinical features, as well as radiological and laboratory investigations to assess patients with IBP. An online, observational questionnaire-based survey was done in 10 West Midlands CCGs including disparate geographical and socioeconomic areas. The survey consisted of 23 questions based on Calin, Berlin and ESSG Criteria for spondyloarthropathies. GPs were asked to rate the importance of a range of symptoms as indications of IBP IBP (10 point scale, range 1–10), and what their views were on which were the most important treatments for patients with suspected inflammatory back pain(4 point scale, range 1–4). The 4 most important symptoms for predicting inflammatory back pain according to our local cohort of GPs were ‘morning stiffness’ ‘sleep disturbances caused by back pain’ ‘insidious onset’ and ‘age of onset’ < 45. Among the treatment options, NSAIDs were ranked as the most important treatment option for IBP. DMARDS were rated as the next most important treatment option, ahead of physiotherapy and anti-TNF therapy. This study has highlighted relative lack of confidence among GPs in the assessment of IBP. Whether this reflects a need for education or poor performance of these questions in primary care populations requires further study.
Literature
1.
Calin A, Porta J, Fries JF et al (1977) Clinical history as a screening test for ankylosing spondylitis. JAMA 237:2613_4CrossRefPubMed
2.
Khan MA (2002) Ankylosing spondylitis: introductory comments on its diagnosis and treatment. Ann Rheum Dis 61(Suppl 3):iii3–7CrossRefPubMedPubMedCentral
3.
Sieper J, Rudwailet M, Baraliakos X et al (2009) The assessment of spondyloarthritis international society(ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis 68(Suppl II):ii1–ii44
4.
Haroon N et al (2013) The impact of tumour necrosis factor inhibitors on radiographic progression in ankylosing spondylitis. Arthritis Rheum 65(10):2645–2654PubMedPubMedCentral
5.
Braun J, Pincus T (2002) Mortality, course of disease and prognosis of patients with ankylosing spondylitis. Clin Exp Rheumatol 20(6 Suppl 28):S16–22PubMed
6.
National Institute for Health and Care Excellence (2016) TNF-alpha inhibitors for ankylosing spondylitis and non radiographic axial spondyloarthropathy (NICE Guideline 383). https://​www.​nice.​org.​uk/​guidance/​ta383
7.
Weisman MH, Witter JP, Reveille JD (2013) The prevalence of inflammatory back pain: population-based estimates from the US National Health and Nutrition Examination Survey, 2009–10. Ann Rheum Dis 72:369–373CrossRefPubMed
8.
Cottrell E (2015) Maximising response from GPs to questionnaire surveys: do length or incentives make a difference? BMC Med Res Methodol 15:3CrossRefPubMedPubMedCentral
9.
General Practioners (2010) BMA briefing paper. 20 October 2010
10.
2014 UK Medical Workforce (2015) BMA briefing paper. May 2015
11.
Braun et al (2011) Identifying patients with axial spondyloarthritis in primary care: how useful are items indicative of inflammatory back pain? Ann Rheum Dis 70(10):1782–1787CrossRefPubMedPubMedCentral
12.
Jones et al (2014) Time to diagnosis of axial spondylarthritis in clinical practice: signs of improving awareness? Rheumatology. https://​doi.​org/​10.​1093/​rheumatology/​keu294 CrossRefPubMed
13.
Adshead et al (2015) A UK best practice model for diagnosis and treatment of axial spondyloarthritis. EMJ Rheumatol 2(1):103–110
14.
Sykes et al (2015) Delay to diagnosis in axial spondyloarthritis: are we improving in the UK? Rheumatology (Oxford) 54(12):2283–2284
15.
Gran JT, Husby G (2003) Epidemiology of ankylosing spondylitis. In: Hochberg MC, Silman AJ, Smolen JS et al (eds) Rheumatology, 3rd edn. Mosby, London, pp 1153–1159
16.
Lambert et al (2015) Defining active sacroiliitis on MRI for classification of axial spondyloarthritis: update by the ASAS MRI working group. Ann Rheum Dis. https://​doi.​org/​10.​1136/​annrheumdis-2015-208642
17.
McVeigh et al (2017) NICE Guideline NG65. Spondyloarthritis in over 16s: diagnosis and management
18.
Jois et al (2008) Recognition of inflammatory back pain and ankylosing spondylitis in primary care. Rheumatology 47(9):1364–1366CrossRefPubMed
19.
Moorthy A, Joseph C (2013) THU0507 is there a knowledge gap in diagnosing inflammatory back pain in primary care? Regional survey among GPS in leicestershire, UK. Ann Rheumatic Dis 72:A335CrossRef
20.
Rudwaleit M et al (2004) How to diagnose axial spondyloarthritis early? Ann Rheum Dis 61:535–543CrossRef